ABBV
AbbVie
October 30, 2026 · pre-market
- Rarity
- 1.31
- Peak move
- +4.09%
- Float cap
- $513.8B
AbbVie is a research-based biopharmaceutical company that develops, manufactures and sells medicines across immunology, oncology, neuroscience, eye care and aesthetics. Its products include Skyrizi and Rinvoq for autoimmune conditions, Botox, Vraylar and Ubrelvy, blood-cancer drugs Imbruvica and Venclexta, and fillers and skincare brands. It sells to hospitals, physicians, pharmacies and consumers in more than 175 countries.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.